Safety and Efficacy of the Combination of Empagliflozin and Linagliptin Compared to Linagliptin Alone Over 24 Weeks in Patients With Type 2 Diabetes
Clinical trial NCT01734785 · COMPLETED
Trial details
- NCT number
- NCT01734785
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-08
- Primary completion
- 2015-03-23
- Enrollment
- 607
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.